Novel Nanomonitor ultra-sensitive detection of troponin T
Troponin is the preferred biomarker for diagnosing myocardial infarction. Point of care devices have not matched the sensitivity of laboratory-based methods for measuring troponin. The Nanomonitor is a novel point-of-care device that uses the change in electrical impedance that occurs when a biomark...
Gespeichert in:
Veröffentlicht in: | Clinica chimica acta 2015-03, Vol.442, p.96-101 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Troponin is the preferred biomarker for diagnosing myocardial infarction. Point of care devices have not matched the sensitivity of laboratory-based methods for measuring troponin. The Nanomonitor is a novel point-of-care device that uses the change in electrical impedance that occurs when a biomarker binds to its antibody, which is then correlated to the concentration of the target biomarker.
Performance characteristics of the Nanomonitor were evaluated and compared to a standard laboratory-based method.
The limit of detection of the Nanomonior for troponin T was 0.0088ng/l. Total imprecission was 2.38% and 0.85% at troponin T concentrations of 73ng/l and 1800ng/l. The functional sensitivity (10% coeffecient of variation) was 0.329ng/l. The linear regression had a slope of 0.996 (95% confidence interval, 0.991, 1.002), r=1.00, and an intercept of 15.88ng/l (95% confidence interval, −68.39ng/l, 100.15ng/l). The mean difference between the assays was −7.54ng/l, determined by Bland–Altman analysis.
The Nanomonitor preliminary results have favorable performance characteristics for detecting troponin T in patient blood, provide results in 15min, and are portable. More research is needed.
•We describe a novel nanotechnology device for measuring troponin T.•The Nanomonitor LOD is 0.0088 ng/L and 10% CV is 0.329 ng/L.•Total imprecision was < 3% for troponin T concentrations of 73 ng/L and 1800 ng/L.•The Nanomonitor has favorable preliminary charachteristics and detects troponin T in patient blood.•The Nanomonitor provides results in 15 min and is portable. |
---|---|
ISSN: | 0009-8981 1873-3492 |
DOI: | 10.1016/j.cca.2015.01.013 |